glp-1 and crohn's Glucagon-like peptide-1 (GLP-1) receptor agonists in inflammatory bowel disease: mechanisms, clinical implications, therapeutic potential GLP-1 based therapies and disease

While highly effective at promoting weight loss, a growing concern among clinicians and patients is the loss of lean muscle mass that often accompanies the drop in body weight

Naltrexone/Bupropion Extended-Release 32 mg/360 mg significantly improves liver enzymes in obese/overweight individuals with elevated liver enzymes

GLP-1Rs located in the hypothalamus suppress appetite by activating satiety pathways, in addition to their role in glycemic control

Prior authorization (PA) We require you or your physician to get prior authorization for certain drugs

The good news is that with the right planning, its possible to balance both your personal health goals and your pregnancy

We also examined observational studies that gathered empirical data on the effects of treatment on patient outcomes